Literature DB >> 25804841

Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.

Jie Tang1, Lili Ji, Yuchan Wang, Yuejiao Huang, Haibing Yin, Yunhua He, Jing Liu, Xiaobing Miao, Yaxun Wu, Xiaohong Xu, Song He, Chun Cheng.   

Abstract

The expression and biologic function of the gene encoding vacuolar protein sorting 4B (VPS4B) in human multiple myeloma (MM) were investigated in this study. We determined that VPS4B expression is decreased in adherent MM cells and that knockdown of VPS4B expression induces cell adhesion-mediated drug resistance (CAM-DR) in MM. This induced CAM-DR phenotype manifested through down-regulation of cell apoptosis and requires phosphorylation of AKT and Erk. Finally, VPS4B expression was positively correlated with cell proliferation. Our findings support a role for VPS4B in MM cell proliferation, adhesion, and drug resistance, and pave the way for a novel therapeutic approach targeting this molecule.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25804841     DOI: 10.1007/s12185-015-1783-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  43 in total

1.  Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1/Vps4.

Authors:  Yuki Ohsaki; Yuko Sugimoto; Michitaka Suzuki; Hiroshi Hosokawa; Tamotsu Yoshimori; Joanna P Davies; Yiannis A Ioannou; Marie T Vanier; Kousaku Ohno; Haruaki Ninomiya
Journal:  J Cell Sci       Date:  2006-06-06       Impact factor: 5.285

2.  Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.

Authors:  Michael F Emmons; Anthony W Gebhard; Rajesh R Nair; Rachid Baz; Mark L McLaughlin; Anne E Cress; Lori A Hazlehurst
Journal:  Mol Cancer Ther       Date:  2011-10-06       Impact factor: 6.261

3.  A preclinical assay for chemosensitivity in multiple myeloma.

Authors:  Zayar P Khin; Maria L C Ribeiro; Timothy Jacobson; Lori Hazlehurst; Lia Perez; Rachid Baz; Kenneth Shain; Ariosto S Silva
Journal:  Cancer Res       Date:  2013-12-05       Impact factor: 12.701

4.  Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

Authors:  T Hideshima; D Chauhan; Y Shima; N Raje; F E Davies; Y T Tai; S P Treon; B Lin; R L Schlossman; P Richardson; G Muller; D I Stirling; K C Anderson
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 5.  The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance.

Authors:  K H Shain; T H Landowski; W S Dalton
Journal:  Curr Opin Oncol       Date:  2000-11       Impact factor: 3.645

6.  Multiple Myeloma: New Insights and Therapeutic Approaches.

Authors:  Kenneth C. Anderson; Robert A. Kyle; William S. Dalton; Terry Landowski; Kenneth Shain; Richard Jove; Lori Hazlehurst; James Berenson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2000

7.  P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.

Authors:  Abdel Kareem Azab; Phong Quang; Feda Azab; Costas Pitsillides; Brian Thompson; Triona Chonghaile; John T Patton; Patricia Maiso; Val Monrose; Antonio Sacco; Hai T Ngo; Ludmila M Flores; Charles P Lin; John L Magnani; Andrew L Kung; Anthony Letai; Ruben Carrasco; Aldo M Roccaro; Irene M Ghobrial
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

8.  Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications.

Authors:  C C Bjorklund; V Baladandayuthapani; H Y Lin; R J Jones; I Kuiatse; H Wang; J Yang; J J Shah; S K Thomas; M Wang; D M Weber; R Z Orlowski
Journal:  Leukemia       Date:  2013-06-13       Impact factor: 11.528

9.  Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma.

Authors:  Angela Zöllinger; Thorsten Stühmer; Manik Chatterjee; Stefan Gattenlöhner; Eugenia Haralambieva; Hans-Konrad Müller-Hermelink; Mindaugas Andrulis; Axel Greiner; Carmen Wesemeier; Jörg C Rath; Hermann Einsele; Ralf C Bargou
Journal:  Blood       Date:  2008-07-17       Impact factor: 22.113

10.  Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.

Authors:  Min Fei; Qinglei Hang; Sicong Hou; Changgeng Ruan
Journal:  Int J Hematol       Date:  2013-09-14       Impact factor: 2.490

View more
  4 in total

1.  Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.

Authors:  Jie Tang; Liqun Zhu; Yuejiao Huang; Bing Shi; Shuqing Zhang; Lingli Gu; Jie Zhao; Minghao Deng; Jiahao Zhu; He Xun; Yuchan Wang; Chun Wang
Journal:  Oncol Lett       Date:  2019-01-11       Impact factor: 2.967

2.  Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer.

Authors:  Ewelina Szymańska; Paulina Nowak; Krzysztof Kolmus; Magdalena Cybulska; Krzysztof Goryca; Edyta Derezińska-Wołek; Anna Szumera-Ciećkiewicz; Marta Brewińska-Olchowik; Aleksandra Grochowska; Katarzyna Piwocka; Monika Prochorec-Sobieszek; Michał Mikula; Marta Miączyńska
Journal:  EMBO Mol Med       Date:  2020-01-13       Impact factor: 12.137

Review 3.  CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.

Authors:  Yuejiao Huang; Yuchan Wang; Jie Tang; Shiyi Qin; Xianjuan Shen; Song He; Shaoqing Ju
Journal:  Front Cell Dev Biol       Date:  2021-07-06

4.  The Multivesicular Bodies (MVBs)-Localized AAA ATPase LRD6-6 Inhibits Immunity and Cell Death Likely through Regulating MVBs-Mediated Vesicular Trafficking in Rice.

Authors:  Xiaobo Zhu; Junjie Yin; Sihui Liang; Ruihong Liang; Xiaogang Zhou; Zhixiong Chen; Wen Zhao; Jing Wang; Weitao Li; Min He; Can Yuan; Koji Miyamoto; Bingtian Ma; Jichun Wang; Peng Qin; Weilan Chen; Yuping Wang; Wenming Wang; Xianjun Wu; Hisakazu Yamane; Lihuang Zhu; Shigui Li; Xuewei Chen
Journal:  PLoS Genet       Date:  2016-09-12       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.